Gene · 6926
Papers2,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Impaired Wound Healing Process Is a Major Factor in Remodeling of the Corneal Epithelium in Adult and Adolescent Patients With Keratoconus. | Invest Ophthalmol Vis Sci | 2023 | 36811882 | PubTator, text mining | PubMed |
| Chromosome-level genome assembly and population genomics of Mongolian racerunner (Eremias argus) provide insights into high-altitude adaptation in lizards. | BMC Biol | 2023 | 36803146 | PubTator, text mining | PubMed |
| Genetic Risk of Primary Aldosteronism and Its Contribution to Hypertension: A Cross-Ancestry Meta-Analysis of Genome-Wide Association Studies. | Circulation | 2023 | 36802911 | PubTator, text mining | PubMed |
| Studying the connection between SF3B1 and four types of cancer by analyzing networks constructed based on published research. | Sci Rep | 2023 | 36792691 | PubTator, text mining | PubMed |
| Genetics and Molecular Basis of Congenital Heart Defects in Down Syndrome: Role of Extracellular Matrix Regulation. | Int J Mol Sci | 2023 | 36769235 | PubTator, text mining | PubMed |
| Dysregulation of Gene Expression of Key Signaling Mediators in PBMCs from People with Type 2 Diabetes Mellitus. | Int J Mol Sci | 2023 | 36769056 | PubTator, text mining | PubMed |
| The oncogenic roles and clinical implications of YAP/TAZ in breast cancer. | Br J Cancer | 2023 | 36759723 | PubTator, text mining | PubMed |
| Genetic and phenotypic continuum of HOXA genes: A case with double HOXA9/HOXA13 mutations. | Mol Med Rep | 2023 | 36734258 | PubTator, text mining | PubMed |
| The landscape of immune dysregulation in Crohn's disease revealed through single-cell transcriptomic profiling in the ileum and colon. | Immunity | 2023 | 36720220 | PubTator, text mining | PubMed |
| An atlas of lamina-associated chromatin across twelve human cell types reveals an intermediate chromatin subtype. | Genome Biol | 2023 | 36691074 | PubTator, text mining | PubMed |
| Expansion of ventral foregut is linked to changes in the enhancer landscape for organ-specific differentiation. | Nat Cell Biol | 2023 | 36690849 | PubTator, text mining | PubMed |
| Roles of conventional and complementary therapies in recurrent hepatocellular carcinoma. | World J Gastrointest Oncol | 2023 | 36684056 | PubTator, text mining | PubMed |
| Chromatin and Cancer: Implications of Disrupted Chromatin Organization in Tumorigenesis and Its Diversification. | Cancers (Basel) | 2023 | 36672415 | PubTator, text mining | PubMed |
| Effect of mechanical unloading on genome-wide DNA methylation profile of the failing human heart. | JCI Insight | 2023 | 36656640 | PubTator, text mining | PubMed |
| Comparative analysis of mesenchymal stem/stromal cells derived from human induced pluripotent stem cells and the cognate umbilical cord mesenchymal stem/stromal cells. | Heliyon | 2023 | 36647346 | PubTator, text mining | PubMed |
| CRISPR-induced exon skipping of β-catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer. | J Pathol | 2023 | 36641763 | PubTator, text mining | PubMed |
| xcore: an R package for inference of gene expression regulators. | BMC Bioinformatics | 2023 | 36631751 | PubTator, text mining | PubMed |
| High cardiomyocyte diversity in human early prenatal heart development. | iScience | 2023 | 36624836 | PubTator, text mining | PubMed |
| TBX3 Promotes Cervical Cancer Proliferation and Migration via HPV E6 and E7 Signaling. | Mol Cancer Res | 2023 | 36622795 | PubTator, text mining | PubMed |
| Feeder cells treated with ethanol can be used to maintain self-renewal and pluripotency of human pluripotent stem cells. | FEBS Open Bio | 2023 | 36537760 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6926/papers?page=15